SCHEMBL3504561

SCHEMBL3504561

CN(C)C(=O)Oc1ccc2c(NCCN3CCOCC3)noc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CLK4 Q9HAZ1 1/20 0.46
▸ CSNK2A1 P68400 1/20 0.41
▸ HSP90AA1 P07900 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ HSP90AB1 P08238 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ HBB P68871 1/20 0.40
▸ LMNA P02545 2/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ BCR P11274 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3504318 0.87 ACHE (0.41) ALDH1A1CYP3A4HSD17B10USP2CYP1A2
SCHEMBL6959886 0.84 ALDH1A1 (0.53) ALDH1A1CYP3A4HSD17B10USP2CYP1A2
SCHEMBL3505069 0.82 GAA (0.45) ALDH1A1HSD17B10KMT2AMEN1LMNA
SCHEMBL8375998 0.82 GAA (0.37) ALDH1A1HSD17B10KMT2AMEN1LMNA
SCHEMBL9388748 0.81 ALDH1A1 (0.40) ALDH1A1HSD17B10CYP1A2HSP90AA1KMT2A
SCHEMBL6951018 0.80 HRH3 (0.45) ALDH1A1HSD17B10KMT2AMEN1LMNA
SCHEMBL3503323 0.80 HSP90AA1 (0.45) ALDH1A1CYP3A4HSD17B10USP2CYP1A2
SCHEMBL9085767 0.78 NR1I3 (0.46) ALDH1A1CYP3A4HSD17B10USP2CYP1A2
SCHEMBL8184622 0.78 CYP3A4 (0.45) ALDH1A1CYP3A4HSD17B10USP2CYP1A2
SCHEMBL3505581 0.78 HSP90AA1 (0.50) ALDH1A1CYP3A4HSD17B10USP2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 — — US claimed
US-20100247543-A1 TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES ORYZON GENOMICS, S.A. (ES) 2010-09-30 — — US disclosed
EP-0669920-B1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS AVENTIS PHARMA INC (US) 2003-02-12 — — EP disclosed
US-6046203-A USEFUL FOR THE TREATMENT OF VARIOUS MEMORY DYSFUNCTIONS CHARACTERIZED BY A DECREASED CHOLINERGIC FUNCTION SUCH AS ALZHEIMER'S DISEASE; ALSO INHIBIT MONOAMINE OXIDASE AND HENCE ARE USEFUL AS ANTIDEPRESSANTS AVENTIS PHARMACEUTICALS INC. (US) 2000-04-04 — — US disclosed
US-5925766-A COGNITION ACTIVATORS FOR DECREASING CHOLINERGIC FUNCTION OF ALZHEIMER*S DISEASE AND ARE ENZYME INHIBITORS OF MONOAMINE OXIDASE AND ARE ANTIDEPRESSANTS HOECHST MARION ROUSSEL, INC. (US) 1999-07-20 — — US disclosed
US-5756754-A Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds HOECHST MARION ROUSSEL, INC. (US) 1998-05-26 — — US disclosed
US-5580982-A ANTIDEPRESSANTS; ANTICHOLINERGIC AGENTS; ALZHEIMER'S DISEASE; AMINE OXIDASE INHIBITORS HOECHST MARION ROUSSEL INC. (US) 1996-12-03 — — US disclosed
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 — — US disclosed
WO-1994012495-A1 SUBSTITUTED 3-(AMINOALKYLAMINO)-1,2-BENZISOXAZOLES AND RELATED COMPOUNDS HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1994-06-09 — — WO disclosed
Send feedback